APA (7th ed.) Citation

Chen, C., Lin, Y., Cheng, L., Lin, C., & Ke, G. (2022). Poloxamer-188 Adjuvant Efficiently Maintains Adaptive Immunity of SARS-CoV-2 RBD Subunit Vaccination through Repressing p38MAPK Signaling. Vaccines, 10(5), 715. https://doi.org/10.3390/vaccines10050715

Chicago Style (17th ed.) Citation

Chen, Chao-Hung, Yu-Jen Lin, Li-Ting Cheng, Chien-Hung Lin, and Guan-Ming Ke. "Poloxamer-188 Adjuvant Efficiently Maintains Adaptive Immunity of SARS-CoV-2 RBD Subunit Vaccination Through Repressing P38MAPK Signaling." Vaccines 10, no. 5 (2022): 715. https://doi.org/10.3390/vaccines10050715.

MLA (9th ed.) Citation

Chen, Chao-Hung, et al. "Poloxamer-188 Adjuvant Efficiently Maintains Adaptive Immunity of SARS-CoV-2 RBD Subunit Vaccination Through Repressing P38MAPK Signaling." Vaccines, vol. 10, no. 5, 2022, p. 715, https://doi.org/10.3390/vaccines10050715.